Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), By Ballon Material (Polyolefin copolymer (POC)

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), By Ballon Material (Polyolefin copolymer (POC), Polyethylene (PE) and Polyethylene terephthalate (PET)), By Application (Peripheral Artery Disease and Coronary Artery Disease), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Percutaneous transluminal coronary angioplasty (PTCA) balloon catheter aims to widen clogged or narrowed coronary arteries to restore proper blood flow to the heart. PTCA is a non-surgical procedure that involves inserting a slender tube called a catheter into an artery, usually in the groin area, and guided it into the coronary arteries using X-ray images to find the clog or narrowing. Once located, a small deflated balloon at the tip of the catheter is inflated, compressing and flattening the plaque to widen the artery. After deflation and removal of the catheter, an empty metal mesh tube called a stent may be placed to keep the artery open. PTCA is considered revolutionary technique that revolutionized treatment of coronary artery disease.

Market Dynamics:

Global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is expected to witness high growth due to the rising prevalence of cardiovascular diseases and the increasing preference for PTCA balloon catheters over open-heart surgeries. Additionally, growing geriatric population, which is more prone to cardiovascular diseases, along with technological advancements in PTCA balloon catheters, further contributes to this market expansion. However, stringent regulatory approval process for new product launches and availability of alternative treatment modality like drug-eluting stents are restraining the market growth. Development of affordable and innovative bioabsorbable stents and advent of new generation drug coated balloons present high growth opportunities for market players.

Key Features of the Study:

• This report provides in-depth analysis of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boston Scientific Corporation, Cardinal Health, BD, Medtronic, Terumo Medical Corporation, Cook Medical, Biotronik, AndraTec, Natec Medical, Shockwave Medical Inc, Nipro Group Companies, Teleflex Incorporated, and MicroPort Scientific Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
• Normal Balloon Catheter
• Drug Eluting Balloon Catheter
• Cutting Balloon Catheter
• Scoring Balloon Catheter
• Ballon Material Insights (Revenue, USD Bn, 2019 - 2031)
• Polyolefin copolymer (POC)
• Polyethylene (PE)
• Polyethylene terephthalate (PET)
• Application Insights (Revenue, USD Bn, 2019 - 2031)
• Peripheral Artery Disease
• Coronary Artery Disease
• End User Insights (Revenue, USD, 2019 - 2031)
• Hospitals
• Ambulatory Surgical Centers
• Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Boston Scientific Corporation
• Cardinal Health
• BD
• Medtronic
• Terumo Medical Corporation
• Cook Medical
• Biotronik
• AndraTec
• Natec Medical
• Shockwave Medical Inc
• Nipro Group Companies
• Teleflex Incorporated
• MicroPort Scientific Corporation